Skip to content

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

In committee: it can still change before the session ends.

US HR 4392 · House Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
House
Sponsors
55
Latest action
Jul 15, 2025

What it does

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 would authorize the Secretary of Health and Human Services to award grants to states for programs that increase early detection and intervention for uterine fibroids, including screening, patient navigation, and public awareness campaigns, with priority given to states targeting socially vulnerable populations at elevated risk. The bill also directs the Secretary to conduct or support research on early detection strategies and disparities in pain control during uterine fibroid treatment, as well as conditions like Asherman’s Syndrome, and requires biennial reports to Congress on grant outcomes and research…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Jul 15, 2025

  2. Committee (Current step)

    In committee · Jul 15, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 | 52